Tom O’Neill has served as president, chief executive officer and member of the Board of Directors at Cognivue^® Inc, the highly respective neuroscience company focused on cognitive health, since 2018. For more than 30 years, his commercial leadership has driven top and bottom-line growth, operational excellence, and improved customer satisfaction across the consumer, pharmaceuticals, medical devices, surgical and diagnostics sectors.

Prior to joining Cognivue, Mr. O’Neill served as president, North American Commercial Operations for Qiagen, a global leader in molecular diagnostics and life sciences, where he helped set the stage for long-term sustainable growth; as president for Hologic’s global gynecologic surgical business, leading its turnaround and significant top and bottom-line divisional success; and as president, North American Commercial Operations for Ortho Clinical Diagnostics, where he inspired 600 professionals to reignite growth for the $850 million business.

From 2009 to 2013, Mr. O’Neill held positions of increasing responsibility at Bausch + Lomb Incorporated, including as vice president and general manager, North American Vision Care. Beforehand, he served in leadership roles with SynergEyes and Valeant Pharmaceuticals. Earlier in his career, he held sales and marketing positions within the Johnson and Johnson Family of Companies including McNeil Consumer Healthcare, J&J/Merck, and Ortho-McNeil Pharmaceuticals.

Mr. O’Neill received a B.S. in Business Administration and Marketing from the University of Akron. He currently sits on Ceek Woman’s Health Board of Directors. He is also very passionate about serving his local community, including his role as president of Gigi’s Playhouse, a Down syndrome development center in Rochester, N.Y.

Samantha “Sam” McDonnell joined the Cognivue team in March 2021 as Vice President of Finance and Human Resources. Sam brings over 10 years of experience as a financial leader within a variety of industries including medical devices, niche manufacturing and distribution, professional services, and telecommunications. Her career has been rich in disrupting the status quo while focused on increasing operational efficiency through process improvement, software implementations, and redesigning financial models.

Prior to joining Cognivue, Sam was the CFO at a local medical device manufacturer, where she was instrumental in managing cash flow for the start-up. Prior to that, she was a member of the Willowood USA LLC executive team that strategically drove a $45M reduction of debt and maneuvered the company’s acquisition by Generic Crop Science. She has a proven track record of leading all accounting and finance functions, managing working capital, and developing forecasting models to promote operational predictability.

Sam received her MBA and B.S. from St. John Fisher College in Rochester, NY.

Whitney Parachek joined Cognivue in August 2018 as Vice President of Sales. Ms. Parachek brings more than 20 years of commercial experience leading and developing high performance teams in the healthcare and device sector.

With a commitment to long term growth, she focuses on performance through the recruitment, development and engagement of high level talent. From 1999 – 2007 Ms. Parachek worked at CYTYC Corporation in various roles of increasing responsibility. In 2008 she joined the Hologic leadership team as part of the Cytyc acquisition. In 2014 she was promoted to Vice President of Sales for the Gynecologic Surgical Division and was tasked with the responsibility of turning around a declining business. During her three year tenure as VP of Sales, she was successful leading over 250 employees to drive double digit growth in a $400M business. In 2017 Whitney was promoted to Vice President Commercial Engagement responsible for ensuring the successful execution of long term strategic plans, engagement, and alignment of business unit integration.

She is driven by her passion to improve the lives of patients through innovative technologies, superior service, and valuable business solutions. Ms. Parachek earned a B.S. in Kinesiology from the College of Charleston in Charleston, South Carolina.

Karen brings over 25 years of experience in leading strategic and commercial excellence for several Fortune 500 medical device companies and most recently private equity-backed companies.  She has been employed by some of the industry’s top healthcare companies including Boston Scientific, Smith and Nephew, Sanofi, and Olympus Corporation of America.

She brings a successful track record for building global growth strategies and tactical execution plans, creating organizational structure that maximizes product launch success, and providing innovative solutions in an ever-changing healthcare environment, all leading to consecutive years of surpassing annual goals.

Prior to joining Cognivue, she served as the Vice President of Marketing for the private equity backed company Z-Medica.  Over 2 years the company successfully grew their healthcare business 31% and penetrated over 65% of the Level I and II Trauma Centers in the United States.  This growth led to a successful acquisition of Z-Medica by Teleflex in December of 2020.

Ms. Parkyn-Michael began her career at Boston Scientific where she held various positions in sales and marketing building the foundation for what would become a multimillion-dollar Women’s Health business.  Next, she took on roles with increasing responsibilities with Smith and Nephew, Sanofi and Olympus Corporation of America.  In each role she was tasked with being a change agent and bringing new thinking to these organizations to enter new markets, expedite growth with existing legacy products and determine approaches to building out the product portfolios.  She has successfully launched over 50 products to the market over her career.  Over these years she has consistently experienced double-digit growth trajectories due to the execution of these strategies.  Additionally, she has built strong relationships and collaborated with Global Key Opinion Leaders, Healthcare Administrators, and Societal Leaders to bring new and innovative products to the market with the interest of patient care at the forefront.

Ms. Parkyn-Michael holds a Bachelor of Science degree in Business Administration from Millersville University.

Susan is an established professional with a proven background within the medical device market of helping companies with Market Access and Business/Product Development.  She has a proven track record of leading contracting, account management, partner alliances, and reimbursement teams to maximize product access and reimbursement.  Susan has worked at large fortune 500 companies such as Abbott and Medtronic – along with helping start-ups Therasense and Telcare become established.

Beginning in 2009, Paul Estes helped conceive and develop Cognivue^® technology, playing integral roles in de novo 510(k) clearance from the U.S. Food and Drug Administration and its commercialization.

Today, as Chief Technology and Operations Officer and a member of the company’s leadership team, he collaborates on planning for technology roadmaps, new product development and expansion, business relations, sales team integration, and staffing. He also holds responsibility for intellectual property management, quality and regulatory affairs, manufacturing, software development, and customer training and support.

Paul has a B.S. degree in Education from Houghton College.

Doug began his professional career at the House Ear Institute (Los Angeles) focused on cochlear implant research and intraoperative cranial nerve monitoring. In 1988, he became Director of Audiology at Saint Louis University. In 1996, he co-founded a multi-office dispensing practice in St Louis.  In 1999, he became President and Editor- In-Chief of AudiologyOnline.com and SpeechPathology.com.  From 2008 through 2015 he served as Web Content Editor for the American Academy of Audiology (AAA).  In 2016 he was appointed Senior Editor for Clinical Research at the Hearing Review and was appointed Adjunct Clinical Professor of Communication Disorders & Sciences at State University of NY at Buffalo. In August 2005 Dr Beck joined Oticon Inc. In 2019 he was appointed Vice President of Academic Sciences at Oticon. After 17 years with Oticon, Beck retired from Oticon March 4, 2022.

Dr. Beck currently consults, lectures, teaches, volunteers and writes for multiple audiology, science, medical, and health-related professional organizations globally. Dr. Beck is among the most prolific authors in audiology with more than 208 publications. To learn more about Dr. Douglas L. Beck Au.D.,  visit www.douglaslbeck.com.

Dung Trinh, MD, is the Chief Medical Officer of Irvine Clinical Research, a Board Member for Alzheimer’s Orange County, a physician with MemorialCare, and is a medical missionary with TongueOut Medical Missions.   He is also the Chief Medical Officer of Astiva Health, a Medicare Advantage Health Plan committed to providing smart and accessible quality healthcare.

Over the years, Dr. Trinh has developed a passion for educating his patients and the community. He provides numerous lectures on a variety of health topics throughout Orange County. In his early days of practicing medicine, he became frustrated with the limited medical treatments available for Alzheimer’s. He is deeply involved in all aspects of Alzheimer’s care, including clinical trials.

Dr. Trinh focuses on the overall health of his patients with a primary focus of preventing Alzheimer’s. He believes it is important to teach his older patients about the progression of the disease and diagnosis in its early stages. His overall practices centers around prevention, diagnosis, and treatment of Alzheimer’s.

Dr. Trinh is a well-known expert in speaking on preventive health including brain health, inflammation, ketosis, and intermittent fasting.

Dr. Trinh serves on several advisory boards, board of directors and helped found several companies ranging from healthcare to e-commerce.